GeneDx Holdings (WGS) EPS (Diluted) Growth (1y) (2021 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 36.90% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 13.90% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 28.42% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -12.34% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 118.87% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 99.97% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 568.14% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 723.10% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 39.75% |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -264.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -264.36% |
| Mar 31, 2026 | -830.56% |
| Dec 31, 2025 | -405.01% |
| Sep 30, 2025 | 13.57% |
| Jun 30, 2025 | 133.16% |
| Mar 31, 2025 | 70.10% |
| Dec 31, 2024 | 119.08% |
| Sep 30, 2024 | 81.29% |
| Jun 30, 2024 | 40.39% |
| Mar 31, 2024 | 74.48% |
| Dec 31, 2023 | 96.48% |
| Sep 30, 2023 | 75.61% |
| Jun 30, 2023 | 78.06% |
| Mar 31, 2023 | -866.10% |
| Dec 31, 2022 | -8,010.64% |
| Sep 30, 2022 | -4,420.73% |
| Jun 30, 2022 | -170.88% |
| Mar 31, 2022 | 99.91% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 100.00% |